Premier (NASDAQ:PINC) Posts Earnings Results, Misses Expectations By $0.04 EPS

Premier (NASDAQ:PINC - Get Free Report) posted its earnings results on Tuesday. The company reported $0.25 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.04), Zacks reports. Premier had a return on equity of 10.74% and a net margin of 11.41%. The company had revenue of $232.22 million during the quarter, compared to analyst estimates of $243.51 million. During the same quarter last year, the firm posted $0.60 earnings per share. The firm's revenue for the quarter was down 13.8% compared to the same quarter last year. Premier updated its FY 2025 guidance to 1.260-1.340 EPS.

Premier Stock Performance

NASDAQ PINC traded down $0.20 during trading on Friday, reaching $18.75. 1,420,921 shares of the company traded hands, compared to its average volume of 1,340,986. Premier has a 1-year low of $17.95 and a 1-year high of $23.56. The stock's 50 day moving average price is $21.68 and its two-hundred day moving average price is $20.93. The company has a market cap of $1.80 billion, a price-to-earnings ratio of 13.79 and a beta of 0.43.

Premier Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Saturday, March 15th. Investors of record on Saturday, March 1st will be given a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 4.48%. The ex-dividend date of this dividend is Friday, February 28th. Premier's dividend payout ratio (DPR) is presently 61.77%.

Insider Buying and Selling

In other news, Director John T. Bigalke sold 1,136 shares of the business's stock in a transaction that occurred on Thursday, December 5th. The stock was sold at an average price of $22.19, for a total value of $25,207.84. Following the transaction, the director now directly owns 23,846 shares of the company's stock, valued at $529,142.74. The trade was a 4.55 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Michael J. Alkire sold 17,415 shares of the stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $23.16, for a total value of $403,331.40. Following the sale, the chief executive officer now owns 520,728 shares in the company, valued at $12,060,060.48. The trade was a 3.24 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 59,425 shares of company stock worth $1,320,242 in the last 90 days. 0.96% of the stock is owned by company insiders.

Analyst Ratings Changes

Several brokerages recently commented on PINC. Robert W. Baird dropped their target price on shares of Premier from $20.00 to $19.00 and set a "neutral" rating on the stock in a report on Wednesday. StockNews.com lowered Premier from a "buy" rating to a "hold" rating in a research note on Tuesday, November 5th. Canaccord Genuity Group decreased their target price on Premier from $21.00 to $19.00 and set a "hold" rating for the company in a research note on Wednesday. Piper Sandler dropped their price target on Premier from $21.00 to $19.00 and set a "neutral" rating on the stock in a research report on Wednesday. Finally, Barclays raised their price objective on shares of Premier from $20.00 to $24.00 and gave the stock an "equal weight" rating in a research note on Wednesday, November 6th. Ten analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, Premier presently has an average rating of "Hold" and a consensus target price of $20.50.

Premier Company Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.